Relugolix
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for Relugolix, covering 2019-03-22 to 2026-06-15. Get the full timeline:
Most recent: Clinical Trial Results: Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate [Phase 3]